CC(C)(C)c1ccc(OCCOCCOc2ccc(C(C)(C)C)cc2S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)c(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?